Ticker Symbol: PODD
Insulet Corporation
$317.01 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001145197
Company Profile
Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 100 Nagog Park
Website: www.myomnipod.com
CEO: Shacey Petrovic
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $156.80
Change:
-$8.24
(
-4.99%)
Days Range: $156.11 - $165.51
Beta: 0.80
52wk. High: $335.91
52wk. Low: $125.82
Ytd. Change -48.93%
50 Day Moving Average: $159.71
200 Day Moving Average: $250.99
Shares Outstanding: 69821118
Valuation
Market Cap: 1.1T
PE Ratio: 174.92
EPS (TTM): 0.8964
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A